Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study

BACKGROUND: Plasma amyloid-β (Aβ) levels are increasingly studied as a potential accessible marker of cognitive impairment and dementia. However, it remains underexplored whether plasma Aβ levels including the novel Aβ peptide 1–38 (Aβ(1–38)) relate to preclinical markers of neurodegeneration and ri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Res Ther
Main Authors: Hilal, Saima, Wolters, Frank J., Verbeek, Marcel M., Vanderstichele, Hugo, Kamran Ikram, M., Stoops, Erik, Arfan Ikram, M., Vernooij, Meike W.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6026500/
https://ncbi.nlm.nih.gov/pubmed/29960604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0395-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados